Therefore, although neither present in 100% of cases nor not specific for LPL, the presence of MYD88 L265P mutations assists in the diagnosis of LPL in the appropriate clinicopathologic context, especially as this variant is only seen in a small percentage of marginal zone lymphomas. This evidence concerns the gene LPL and marginal zone lymphoma.